ARCHIVES

Cancer Panel To Examine Health Of Phase I Trials

This article is from The Cancer Letter archive.

Vol. 22 No. 20 | May 17, 1996

Download PDF Visit The Full Archive

Related Articles

Burton’s Clinic Reopens; Some Insurers Reportedly Reimbursing; New York Congressman Calls For Evaluation

March 28, 1986

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

February 17, 2012

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Howard Hughes Medical Institute Appoints 12 Physician Investigators

May 31, 2002

O’Leary Leads RPCI’s OR;

February 8, 2002

President Accepts Compromise On HEW Money Bill; Cancer Gets $523.6 Million

December 21, 1973